424B5 EX-FILING FEES 0001829667 333-294722 N/A N/A 0001829667 1 2025-10-10 2025-10-10 0001829667 2025-10-10 2025-10-10 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-3

Regencell Bioscience Holdings Limited

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Ordinary share, par value US$0.00001 per share   (1)   457(r)   985,222   $ 20.30   $ 20,000,006.60   0.0001381   $ 2,762.00
                                           
Total Offering Amounts:   $ 20,000,006.60         2,762.00
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 2,762.00

 

__________________________________________
Offering Note(s)

(1) The amount of registration fee is calculated in accordance with Rule 456(b) and Rule 457(r) of the Securities Act of 1933, as amended and relates to the registration statement on Form F-3 (File No. 333-294722) (the “registration statement”) filed by the registrant. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, the registration statement also covers any additional securities that may be offered or issued in connection with any share split, share dividend or pursuant to anti-dilution provisions of any of the securities.

The proposed maximum aggregate offering price has been estimated solely for purposes of calculating the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended.